EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinicopathological characteristics associated with the prognosis of recurrent gonadotroph tumors

Chrysi Kaparounaki, Alexandre Vasiljevic, Emmanuel Jouanneau, Camille Sergeant, Gérald Raverot iD, Mirela-Diana Ilie iD

Endocrine-Related Cancer · 2025

DOI: 10.1530/erc-24-0186 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Endocrine-Related Cancer, 2025. Verfasst von Chrysi Kaparounaki und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although gonadotroph tumor regrowth is frequent after pituitary surgery, the systematic use of adjuvant radiotherapy is limited by its long-term complications. In this context, it is important to predict which tumors are most likely to regrow after surgery, and especially, which tumors are most likely to regrow rapidly. Clinicopathological characteristics associated with the prognosis of radiotherapy-naïve, recurrent pituitary tumors are currently unknown. In this longitudinal, observational, retrospective, monocentric cohort study, we analyzed the clinicopathological characteristics associated with the prognosis of recurrent, radiotherapy-naïve gonadotroph tumors, specifically with the progression-free survival after a second pituitary surgery. We found that the Ki67 index of radiotherapy-naïve, recurrent gonadotroph tumors was the only parameter statistically associated with the progression-free survival after a second pituitary surgery, P = 0.02. Specifically, radiotherapy-naïve gonadotroph tumors with a positive Ki67 index had shorter progression-free survival after the second surgery (median 31 months) compared to radiotherapy-naïve gonadotroph tumors with a negative Ki67 index (median 75 months). Thus, our study pinpoints that the Ki67 index could be used to guide the management strategy for recurrent gonadotroph tumors that are still radiotherapy-naïve by the time of the second pituitary surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsNeoplasm Recurrence, LocalHumansFemaleMaleRetrospective StudiesMiddle AgedPrognosisAdultAgedKi-67 AntigenYoung AdultLongitudinal Studies

Stichwörter der Autor:innen

gonadotroph adenomapituitary adenomapituitary tumorprogression-free survivalrecurrence

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

ORCID-Profile: Gérald Raverot, Mirela-Diana Ilie

Zitieren

APA

Kaparounaki, C., Vasiljevic, A., Jouanneau, E., Sergeant, C., Raverot, G., & Ilie, M. D. (2025). Clinicopathological characteristics associated with the prognosis of recurrent gonadotroph tumors. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0186

Vancouver

Kaparounaki C, Vasiljevic A, Jouanneau E, Sergeant C, Raverot G, Ilie MD. Clinicopathological characteristics associated with the prognosis of recurrent gonadotroph tumors. Endocrine-Related Cancer. 2025. doi:10.1530/erc-24-0186

BibTeX
@article{Kaparounaki2025,
  author = {Kaparounaki, Chrysi and Vasiljevic, Alexandre and Jouanneau, Emmanuel and Sergeant, Camille and Raverot, Gérald and Ilie, Mirela-Diana},
  title = {Clinicopathological characteristics associated with the prognosis of recurrent gonadotroph tumors},
  journal = {Endocrine-Related Cancer},
  year = {2025},
  doi = {10.1530/erc-24-0186}
}
Kostenlos starten →